Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Seres Therapeutics, Inc.
| Metric | Seres Therapeutics, Inc. MCRBHealthcare |
|---|---|
| Quality Score | 62 / 100 |
| Revenue (latest) | $789,000 |
| Net income (latest) | $6M |
| Operating margin | −11910.1% |
| Net margin | 721.9% |
| Return on equity | 12.9% |
| Return on assets | 4.1% |
| Return on capital (ROCE) | −79.1% |
| Debt / equity | 2.13× |
| Revenue growth (YoY) | — |
| Altman Z″ (distress) | -25.59 |
| Accruals / assets | 3.3% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.